Su Dandan, Lai Xiaolin, Lin Zhizhe, Xu Youfa, Fu Zhiqin, Chen Jianming, Wu Xin
Fujian University of Traditional Chinese Medicine, No. 1 Qiuyang Road, Fuzhou, 350122, China.
Shanghai Wei Er Lab, Shanghai, 201707, China.
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar 17. doi: 10.1007/s00210-025-04039-5.
Cancer chemotherapy is often limited by insufficient drug targeting, which can cause severe adverse effects on healthy tissues. The advent of nanodelivery systems offers a potential solution to this issue. It intricately enhances drug accumulation in tumor regions, while optimizing drug solubility, ensuring colloidal stability, and promoting cellular uptake, significantly improving the precision and efficacy of treatment, opening a gentler yet more effective new path for cancer therapy. This article begins with the pathogenesis of breast cancer and extends to the current treatment methods and their shortcomings, exploring in-depth the targeting therapeutic effects of five innovative nanodelivery technologies used in the treatment of breast cancer in recent years. Finally, it discusses the potential opportunities and challenges that nanodelivery systems may face in future development.
癌症化疗常常受到药物靶向不足的限制,这可能会对健康组织造成严重的副作用。纳米递送系统的出现为这一问题提供了一个潜在的解决方案。它能巧妙地增强药物在肿瘤区域的积累,同时优化药物溶解度、确保胶体稳定性并促进细胞摄取,显著提高治疗的精准度和疗效,为癌症治疗开辟了一条更温和但更有效的新途径。本文首先介绍乳腺癌的发病机制,进而阐述当前的治疗方法及其缺点,深入探讨近年来用于治疗乳腺癌的五种创新纳米递送技术的靶向治疗效果。最后,讨论了纳米递送系统在未来发展中可能面临的潜在机遇和挑战。